Fund View

Fund View

fund.cnfol.com

1

About this website

Founded in 2007 by a team of financial technology entrepreneurs, the platform emerged from a small Beijing office with a vision to democratize investment research for retail traders. What began as a niche data aggregation service transformed into one of Asia's most comprehensive investment information ecosystems after securing Series A funding in 2010. By 2015, the platform had grown to serve over 12 million registered users, becoming a dominant force in China's fintech landscape under the parent company of China Finance Online Corporation. The platform distinguishes itself through proprietary analytics tools that process more than 50 terabytes of market data daily. Its flagship feature, the Real-time Sentiment Index, employs natural language processing to analyze investor forums and social media, generating sentiment scores for over 5,000 stocks with 95% accuracy. Another unique offering is the Institutional Flow Tracker, which aggregates and visualizes fund manager movements across 200+ institutional accounts, revealing patterns invisible in traditional reports. Revenue reached $78 million in 2022, with 65% coming from premium subscriptions and 35% from data licensing to financial institutions. The platform commands approximately 38% market share in China's independent investment research sector, competing with established players like Wind Information and iFind. Its user base includes 3.2 million active premium subscribers who pay between $19-$99 monthly for advanced tools like the Quantitative Backtesting Engine. Strategic partnerships include collaborations with Shanghai Stock Exchange and Shenzhen Stock Exchange for real-time data feeds, as well as integration with Ant Group's Alipay ecosystem for mobile trading interfaces. The platform's research team, led by former Morgan Stanley analyst Zhang Wei, produces daily briefings read by over 800,000 professionals

Tags & Categories

Categories

Tags

Statistics

1
Views
0
Clicks
0
Like
0
Dislike

Comments

Log In to post a comment

No comments yet. Be the first!